A multi–Chinese blood center study testing serologic-negative donor samples for hepatitis C virus and human immunodeficiency virus with nucleic acid testing-Reference-Cited by-同舟云学术

A multi–Chinese blood center study testing serologic-negative donor samples for hepatitis C virus and human immunodeficiency virus with nucleic acid testing

Published:2007-11 Issue:11 Volume:47 Page:2011-2016
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

Shan Hua,Ren Fu-rong,Zhao Hai-yan,Zhang Yuan-zhi,Wen Guo-xing,Yao Fu-zhu,Gao Guo-jing,Yan Li-xing,Jiang Chao-fu,Bai Xu-hua,Tiemuer Mei-hei-li,Tu Yuan-quan,Zhu Fa-ming,Zheng You-rong,Cui Li,Liu Chang-li,Gong Xiao-yan,Lv Qiu-shuang,Zheng Peng,Ziermann Rainer,Ness Paul,Wang Jing-xing

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1537-2995.2007.01424.x/fullpdf

Reference21 articles.

1. Detection of HIV-1 and HCV Infections among Antibody-Negative Blood Donors by Nucleic Acid–Amplification Testing

2. High throughput screening of 16 million serologically negative blood donors for hepatitis B virus, hepatitis C virus and human immunodeficiency virus type-1 by nucleic acid amplification testing with specific and sensitive multiplex reagent in Japan

3. HCV NAT in Austria

4. Yield of HCV and HIV‐1 NAT after screening of 3.6 million blood donations in central Europe

5. Trends in risk of transfusion-transmitted viral infections (HIV, HCV, HBV) in France between 1992 and 2003 and impact of nucleic acid testing (NAT)

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of nucleic acid testing to detect human immunodeficiency virus, hepatitis C virus, and hepatitis B virus yields from a single blood center in China with 10-years review;BMC Infectious Diseases;2022-03-23

2. The power of collaboration;Transfusion;2016-12

3. Epidemiology of hepatitis C in Islamic Republic of Iran;Asian Pacific Journal of Tropical Disease;2016-12

4. APASL consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testing;Hepatology International;2016-05-26

5. KASL clinical practice guidelines: management of hepatitis C;Clinical and Molecular Hepatology;2016-03-28